drugset / Trial / NCT04860635
Safety of F14 Following Total Knee Replacement
NaSingle-groupOpen-labelTreatment
Summary
Open-label single-arm study in which all subjects receive F14 as part of a scheduled TKR and multimodal analgesia
Timeline
- Start
- 2027-01
- Primary completion
- 2028-07
- Completion
- 2028-07
Outcome
Outcome not reported
Stopped: “Study superseded by alternative Phase 3 trial”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Celecoxib | Other / unclassified | — | Other |
Indications
No indication recorded.